Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity - Test2 - elhamkhani - TriplyDB

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

http://www.wikidata.org/entity/Q29196526

about

How does Zika virus cause microcephaly?Transposon mutagenesis of the Zika virus genome highlights regions essential for RNA replication and restricted for immune evasion.ADE-ing and Abetting Zika.Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.Delineating antibody recognition against Zika virus during natural infection Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.Macaque monkeys in Zika virus research: 1947-present.DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests.Impact of Zika virus for infertility specialists: current literature, guidelines, and resources.Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.Taking the Defensive: Immune Control of Zika Virus Infection.Antagonism of type I interferon by flaviviruses.A novel mechanism of antibody-mediated enhancement of flavivirus infection.A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.Zika virus infection confers protection against West Nile virus challenge in mice.Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques.Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not Alter the Production of Interleukin 6 in FcγRII-Expressing K562 Cells.Flavivirus cross-reactivity, Guillain-Barré syndrome, and hematopoietic stem cell transplant patient: Comment response.Non-human Hosts and Zika Virus Maintenance.Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model.Zika virus (ZIKV) Replication is Substantially Inhibited by Novel Favipiravir and Interferon-alpha Combination Regimens.Assessing the population at risk of Zika virus in Asia - is the emergency really over?Analysing increasing trends of Guillain-Barré Syndrome (GBS) and dengue cases in Hong Kong using meteorological data.Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo.Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge.T Cell Immunity to Zika and Dengue Viral Infections.Virus and Antibody Dynamics in Travelers With Acute Zika Virus Infection.Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction.Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.Development of Zika Virus Vaccines.Immune Response to Dengue and Zika.Sustained specific and cross-reactive T cell responses to Zika and Dengue viruses NS3 in West Africa.

P2860

Q30145540-79DDB75C-CBD5-41B4-A9C7-D44781860B5C Q30145598-23C60906-13D1-4FCD-BD5E-00972DD76C83 Q30145626-0C56EC73-F15B-4CD1-B782-9DA574E20B56 Q30145645-06F0E6E9-4527-46BE-9B7B-2F6857730E7F Q30145646-95E85C23-0878-4F4F-AE72-65728931E9F9 Q33798068-ECA1440A-6C18-46C4-98D5-1A2C577F7D8A Q33850577-CE1086DC-18B0-4CE2-89EC-A6686E47A1A4 Q33911252-ED2DF6F3-40BF-492A-9FC6-00662EA56E97 Q38156536-325CB5B5-18F1-4423-A7AA-74B667A31CF5 Q38156667-A97F3768-B295-4681-820C-A7D400CB6C10 Q38156674-4C07AEE3-1DD3-4097-8B84-ACD521A7183C Q38157306-2C2518C7-170A-4284-B46D-C9EABA728E6E Q38157397-F5C58085-7C89-44DA-9C5D-4CDA2CC802CD Q38157439-0FBF9543-94A9-40E3-A858-A783D242CF2D Q38158070-B927D4FD-1C8B-4AEF-9D20-F84592D4BA4C Q38158407-D6C9B490-2681-4F99-9C01-E5753B37E6D3 Q38848948-1066EB9A-6384-4669-B2E6-ECF5406306C1 Q39347222-D22D3ABF-AAB9-4BA6-AE22-ABCEB0FEE5F2 Q40038769-AC4CEC2C-5F81-4CB6-9207-605416FEC5E7 Q41596362-66F1BC81-5B20-4882-AD13-90DB806F32C3 Q41918368-AAFD2333-1203-49A0-ACE5-AFDBC6E0E4C5 Q41924121-1B980EE7-75A2-4A46-B6FB-6E5D4C2123A1 Q41995967-1C70F835-33C4-4ABE-9C56-05026FEDD0B6 Q43038325-615D5010-7DB9-46C6-9B3B-BA4D9AE3138C Q43038878-F25F6882-83BC-47E6-BAB6-D3AF97FCF3C5 Q43046666-0670653E-0E62-4B1D-AA20-99A521A17F31 Q43046676-00B6EC04-85F8-4E56-A216-E03B820ADCF8 Q43046770-E89D63AC-8962-4792-AD23-ABA17D83AAE8 Q43047028-C2BCFA52-034D-45DE-8EC5-A2C8020C449E Q44843450-58C183A8-306B-49DC-BEE4-A6571C587208 Q45324313-94AF6347-054F-4772-8998-BC94C27C1115 Q45324929-7FABF831-4BA8-4126-ADA0-FF4E5F2E116B Q46518619-DCE23F85-18B7-4804-A3E0-BACCD3313E98 Q47232695-0C2C7210-1BD6-4541-B02C-67E740533A31 Q47315490-867F42E1-EB33-457A-9E38-7E48D2807224 Q47548142-304269D7-6A07-4B92-AEFB-974A36202B14 Q47550067-EC6FA33F-01F3-47BA-AF95-05A82DE712F2 Q47551875-FDE50A1E-0D21-49F6-95F0-795419AD8A43 Q47551925-FC520FE7-9F53-4499-94D0-D28EB64D3F55 Q47555900-B8ECF9F3-D06F-4F2C-9C3A-0133D38599A8

P2860

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

http://www.wikidata.org/entity/Q29196526

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

@ast

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

@en

type

label

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

@ast

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

@en

prefLabel

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

@ast

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

@en

P1433

Q29196526-DEDCADEF-B517-412D-92D8-3DBBA28C112E

P1476

Q29196526-E7ADEF7E-FF5B-42BD-95A6-79E06650AB5E

P2093

Q29196526-7639AFD1-D6C8-400B-86B5-ACD1CAC85E38

Q29196526-D700D69D-6126-490A-9366-5DD25B8B594D

Q29196526-F3B1CE6B-C502-4733-B4BE-5D20B110D4EF

P2860

Q29196526-0AA10B61-C002-4946-811B-7ABC112772F5

Q29196526-15EE74E3-9205-495E-A6CE-822CAA515EA1

Q29196526-185429C9-3B82-4285-AC74-0CCD6AF92C43

Q29196526-19DDB98E-39F1-414D-B2E9-DBF12ED994BE

Q29196526-25F6611A-C011-422E-A8A7-BC349118C218

Q29196526-266E7EEC-86ED-48C2-8750-7E7B0141F8BC

Q29196526-2B83CB69-3A60-4936-BDB8-E0384F9FA38E

Q29196526-2BCC3675-3E8E-445B-BAFD-93E996EE695D

Q29196526-31A8BD8E-C0D7-4498-B3DB-48D6076134AA

Q29196526-32E7CD0D-2208-4262-8A89-56C812338547

P304

Q29196526-A69C4420-22D3-44F5-BE2A-E8C7A40B66E6

P31

Q29196526-B46DCAB3-0654-45CE-95BE-C9417A91117F

P356

Q29196526-1E95A6F8-2084-45AA-92BE-1986FC356E18

P407

Q29196526-280B7E8A-864D-429E-96FF-7CD0022A9252

P433

Q29196526-D23EEA1D-C7E4-4111-9F2C-EC46C4E600DF

P478

Q29196526-7E470075-9592-4057-BBDC-C3DA691CAE60

P50

Q29196526-09A3465A-5AA9-4F27-8CC3-FCC36DDBF17A

Q29196526-145DE7F7-881D-4E5F-B6CB-97B10DB8BBE3

Q29196526-38BE6FC7-0640-4C98-9E74-2A99BD9E3BC9

Q29196526-4691AA0A-A7F4-42AB-A97B-BB8CCA5E168C

Q29196526-52310A73-F3DF-4F88-847C-46842BD301CA

Q29196526-6EDE3062-B160-4A5D-8938-C82ECE80196B

Q29196526-71116A42-6FF7-4905-AD3D-100BE9306D10

Q29196526-72E236FE-376C-40E7-A2B3-8B02FE0B0F60

Q29196526-79E4ECF7-EECB-4A3B-8F4B-56D18BF1D3BB

Q29196526-B535FB77-6849-413E-A27F-A9BB4430F471

P5008

Q29196526-7DAC629D-D879-441B-9D55-C31B43D4C74F

P577

Q29196526-8FB62F7B-0241-4DA8-9873-CDBE3987483D

P698

Q29196526-D87C97CE-DF68-41EE-A87F-40FFA625A20B

P921

Q29196526-1D25AC13-B681-4CE8-85B1-DA6A923F1145

Q29196526-F1AEAF98-9936-4569-8BE1-FECA1A21D76B

P932

Q29196526-AF466486-E1F3-4CAD-A172-13A90A089560

P356

SCIENCE.AAL4365

P1433

P1476

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

@en

P2093

Gregory A Foster

http://www.w3.org/2001/XMLSchema#string

Julia A Brown

http://www.w3.org/2001/XMLSchema#string

Susan L Stramer

http://www.w3.org/2001/XMLSchema#string

P2860

Zika virus. I. Isolations and serological specificity

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007

Antigenic relatedness of selected flaviviruses: study with homologous and heterologous immune mouse ascitic fluids

The 3.8 Å resolution cryo-EM structure of Zika virus

Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling

NS5 of dengue virus mediates STAT2 binding and degradation

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

P304

175-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAL4365

http://www.w3.org/2001/XMLSchema#string

P407

P433

6334

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P50

Domenico Tortorella

Raffael Nachbagauer

Adolfo García-Sastre

Florian Krammer

Susana V Bardina

Shashank Tripathi

P5008

WikiProject Zika Corpus

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28360135

http://www.w3.org/2001/XMLSchema#string

P921

P932

5714274

http://www.w3.org/2001/XMLSchema#string